Clinical Trial

A Prospective, Randomized, Double-blinded, Controlled, Split-face, Non-inferiority Clinical Investigation Comparing the Safety and Performance of RefillHA Solid With Hydryalix Ultra Deep Lidocaine for the Correction of Moderate-to-severe Nasolabial Folds.

Completed
View on ClinicalTrials.gov →
Summary
Prospective, controlled, randomized, monocentric, double-blind, split-face non-inferiority clinical study to evaluate the safety and performance of injectable implant based on hyaluronic acid hydrogel with lidocaine for correction of moderate-to-severe nasolabial folds
Trial Details
NCT Number NCT07736703
Lead Sponsor Glyance
Conditions Wrinkles and Folds
Enrollment 12 participants
Start Date 2024-12-08
Primary Completion 2026-01-25 (estimated)
Study Completion 2026-01-25 (estimated)
Updated on ClinicalTrials.gov 2026-07-30